These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7522689)

  • 1. Heparin mediates binding of S-protein/vitronectin to the envelope glycoprotein of the human immunodeficiency virus and CD4.
    Su HR; Boackle RJ
    Int Arch Allergy Immunol; 1994 Nov; 105(3):238-44. PubMed ID: 7522689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV.
    Lederman S; Gulick R; Chess L
    J Immunol; 1989 Aug; 143(4):1149-54. PubMed ID: 2545782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human milk glycosaminoglycans inhibit HIV glycoprotein gp120 binding to its host cell CD4 receptor.
    Newburg DS; Linhardt RJ; Ampofo SA; Yolken RH
    J Nutr; 1995 Mar; 125(3):419-24. PubMed ID: 7876916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides.
    Batinić D; Robey FA
    J Biol Chem; 1992 Apr; 267(10):6664-71. PubMed ID: 1551875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4.
    Harrop HA; Rider CC
    Glycobiology; 1998 Feb; 8(2):131-7. PubMed ID: 9451022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-binding domain of human fibronectin binds HIV-1 gp120/160 and reduces virus infectivity.
    Bozzini S; Falcone V; Conaldi PG; Visai L; Biancone L; Dolei A; Toniolo A; Speziale P
    J Med Virol; 1998 Jan; 54(1):44-53. PubMed ID: 9443108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfated polyanions prevent HIV infection of lymphocytes by disruption of the CD4-gp120 interaction, but do not inhibit monocyte infection.
    Lynch G; Low L; Li S; Sloane A; Adams S; Parish C; Kemp B; Cunningham AL
    J Leukoc Biol; 1994 Sep; 56(3):266-72. PubMed ID: 7521897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly sulfated glycosaminoglycans augment the cross-linking of vitronectin by guinea pig liver transglutaminase. Functional studies of the cross-linked vitronectin multimers.
    Sane DC; Moser TL; Parker CJ; Seiffert D; Loskutoff DJ; Greenberg CS
    J Biol Chem; 1990 Feb; 265(6):3543-8. PubMed ID: 1689304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulphated polysaccharides exert anti-HIV activity at differing sites.
    Harrop HA; Rider CC; Coombe DR
    Biochem Soc Trans; 1992 May; 20(2):163S. PubMed ID: 1397551
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of heparin cofactor II function by S protein (vitronectin) and formation of a ternary S protein-thrombin-heparin cofactor II complex.
    Preissner KT; Sié P
    Thromb Haemost; 1988 Dec; 60(3):399-406. PubMed ID: 2976993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells.
    Mbemba E; Benjouad A; Saffar L; Gattegno L
    Virology; 1999 Dec; 265(2):354-64. PubMed ID: 10600606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method to analyze the interaction between gp120 of human immunodeficiency virus and CD4.
    Lanza P; Washington LC; Zanetti M
    Viral Immunol; 1992; 5(4):305-10. PubMed ID: 1472279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural requirements of glycosaminoglycans for their interaction with HIV-1 envelope glycoprotein gp120.
    Matos PM; Andreu D; Santos NC; Gutiérrez-Gallego R
    Arch Virol; 2014 Mar; 159(3):555-60. PubMed ID: 24046088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of binding of rgp120 by anti-HIV active tannins.
    Weaver JL; Pine PS; Dutschman G; Cheng YC; Lee KH; Aszalos A
    Biochem Pharmacol; 1992 Jun; 43(11):2479-80. PubMed ID: 1610410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the collagen-binding of endogenous serum vitronectin by heating, urea and glycosaminoglycans.
    Ishikawa M; Hayashi M
    Biochim Biophys Acta; 1992 May; 1121(1-2):173-7. PubMed ID: 1376146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polyanion binding site on the CD4 molecule. Proximity to the HIV-gp120 binding region.
    Parish CR; Low L; Warren HS; Cunningham AL
    J Immunol; 1990 Aug; 145(4):1188-95. PubMed ID: 2380554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ability of suramin to block CD4-gp120 binding is reversed in the presence of albumin.
    Yao XJ; Wainberg MA; Richard M; Pollak M
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2636-8. PubMed ID: 1810199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitronectin binds to the gonococcal adhesin OpaA through a glycosaminoglycan molecular bridge.
    Duensing TD; Putten JP
    Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):133-9. PubMed ID: 9693112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 p17 binds heparan sulfate proteoglycans to activated CD4(+) T cells.
    Poiesi C; De Francesco MA; Baronio M; Manca N
    Virus Res; 2008 Mar; 132(1-2):25-32. PubMed ID: 18036696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological characterization of human vitronectin and its binding to glycosaminoglycans.
    Akama T; Yamada KM; Seno N; Matsumoto I; Kono I; Kashiwagi H; Funaki T; Hayashi M
    J Biochem; 1986 Nov; 100(5):1343-51. PubMed ID: 2434472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.